<DOC>
	<DOC>NCT01184222</DOC>
	<brief_summary>SENGO-CAM study is a sham-controlled simple blind trial which aim is to study the efficacy of great occipital nerve stimulation (GONS) associated with medication withdrawal in the treatment of medication overuse headache occurring in migraine patients.</brief_summary>
	<brief_title>Efficacy Evaluation Of Great Occipital Nerve Electrical Stimulation On Rebound Headache</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<criteria>age &gt; 18 years old migraine patient with medication overuse headache by non specific analgesics according to the ICHDII diagnostic criteria failure of outpatient withdrawal Signature of informed consent. Affiliation to French national health and pensions organization pregnancy (positive pregnancy test at prestudy) and breastfeeding patients with medication overuse headache by specific antimigraine treatment (triptans or/and ergot derivatives) according to the ICHDII diagnostic criteria previous surgical treatment targeting great occipital nerves</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>